Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary

for all patients with diabetes who are undergoing elective PCI or for those patients undergoing complex procedures. 7.10 A GP IIb/IIIa inhibitor is not used for patients who are undergoing procedurally uncomplicated, elective single-vessel PCI, unless unexpected immediate complications occur. 7.11 Local clinical audits on the care of patients with ACS also could include criteria on other aspects of care referred to in the National Service Framework for Coronary Heart Disease.
